Abstract:

This paper was carried on an Investigation in Hurungwe district, Doro catchment area following confirmation of a measles Igm measles positive case. Doro clinic is 56 km from the district hospital, in the western direction and the laboratory confirmed case is 20 km in the same direction. The community derives its income from tobacco and maize farming. Their religion is Christianity. The area has some hard- to-reach families by district and by religion.

Several cases on measles were detected and filed following the laboratory confirmation.

Based on the findings from the investigation, the following are recommend: VHW Mberikwenyanga to visit the Phiri family (vaccine objectors) to actively search for clinical measles cases and refer, Continued information giving at gatherings and homesteads by community leaders and Community-based Health Workers, Community-based active search by VHWs, Continued information-giving to the community, Continued Active search for more cases, Continued monitoring of the index case, especially nutrition-wise, Conduct headcount of children below 1 year and 5 years, Indicate populations by village, by hard-to-reach on the REC Map, Continued mobilisation and distribution of resources and logistics, Conduct operational research, since the child received 2 valid measles dose, Urgent replacement of obsolete refrigerators and fridge tags

Keywords: Laboratory Investigation, Measles, Hurungwe District, Doro Clinic.

References:

[1].   Atrsheuskaya AV, Kulak MV, Neverov AA, Rubin S, Ignatyev GM. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005. Vaccine. 2008 Apr 16; 26(17):2111-8.

[2].   Campbell C, Levin S, Humphreys P, Walop W, Brannan R. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr. 2005 Dec 15; 5:47.

[3].   Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008 Apr 1; 197(7):950-6.

[4].   Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC. Persistence of vaccineinduced antibody to measles 26-33 years after vaccination. J Infect Dis. 2004 May 1; 189 Suppl 1:S123-30.

[5].   Enquselassie F, Ayele W, Dejene A, Messele T, Abebe A, Cutts FT, Nokes DJ. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect. 2003 Jun; 130 (3):507-19.

[6].   Hirose M, Hidaka Y, Miyazaki C, Ueda K, Yoshikawa H. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination. Scand J Infect Dis. 1997; 29 (2):187-90.

[7].   Nandy R, Handzel T, Zaneidou M, Biey J, Coddy RZ, Perry R, Strebel P, Cairns L. Casefatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis. 2006 Feb 1; 42 (3):322-8.

[8].   Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1; 189 Suppl 1:S4-16.

[9].   Samb B, Aaby P, Whittle HC, Seck AM, Rahman S, Bennett J, Markowitz L, Simondon F. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J. 1995 Mar; 14 (3):203-9.

[10].         WHO: Progress in global measles control and mortality reduction, 2000–2007. Wkly Epidemiol Rec 2008; 83, 441–448.

[11].         Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009 Feb; 38 (1):192-205.